US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist

13.730
+0.180+1.33%

Trading Feb 26 15:32 ET

1.40BMarket Cap-3.84P/E (TTM)

Dyne Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dyne Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Dyne Therapeutics Earnings Reports

Dyne Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 13:07 ET

Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 12, 2024 09:27 ET

Dyne Therapeutics | 8-K: Dyne Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

Aug 12, 2024 17:17 ET

Dyne Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 12, 2024 17:07 ET